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Both strands of human mtDNA are transcribed in
continuous, multigenic units that are cleaved into
the mature rRNAs, tRNAs, and mRNAs required
for respiratory chain biogenesis. We sought to sys-
tematically identify nuclear-encoded proteins that
contribute to processing of mtRNAs within the
organelle. First, we devised and validated amultiplex
MitoString assay that quantitates 27 mature and
precursor mtDNA transcripts. Second, we applied
MitoString profiling to evaluate the impact of
silencing each of 107 mitochondrial-localized, pre-
dicted RNA-binding proteins. With the resulting
data set, we rediscovered the roles of recently
identified RNA-processing enzymes, detected unan-
ticipated roles of known disease genes in RNA
processing, and identified new regulatory factors.
We demonstrate that one such factor, FASTKD4,
modulates the half-lives of a subset of mt-mRNAs
and associates with mtRNAs in vivo. MitoString
profiling may be useful for diagnosing and decipher-
ing the pathogenesis of mtDNA disorders.INTRODUCTION
Human mtDNA encodes 13 protein subunits of the respiratory
chain, as well as the two rRNAs and 22 tRNAs required for
their translation. All protein factors that are required for mtDNA
replication, transcription, and translation are nuclear encoded
and imported into the mitochondrion. Mutations in either
nuclear- or mitochondrial-encoded genes cause a range of
heritable disorders with overlapping phenotypes. Expression
of nuclear- and mtDNA-encoded oxidative phosphorylation
(OXPHOS) complex proteins is coordinated by nuclear tran-
scription factors and coactivators (Scarpulla et al., 2012). How-
ever, local control of mtDNA expression is also possible, as
suggested by the finding that chemical perturbations are
capable of decoupling the expression of the two genomes
(Wagner et al., 2008).918 Cell Reports 7, 918–931, May 8, 2014 ª2014 The AuthorsThe 16.5 kB human mitochondrial genome is highly compact
and transcribed by mtRNA polymerase as two continuous
polycistrons, one for each strand. The ‘‘heavy strand’’ expresses
two rRNAs, 14 tRNAs, and 12 mRNAs, while the ‘‘light strand’’
expresses the ND6 mRNA and eight tRNAs (Figures 1A and
1B). These precursor RNAs primarily contain mt-mRNAs ‘‘punc-
tuated’’ by tRNAs, whose structure is proposed to guide the
cleavage responsible for liberating individual mt-mRNAs and
tRNAs (Anderson et al., 1981; Ojala et al., 1981). Cleavage at
the 50 end of tRNAs is catalyzed by the RNase P complex, which
is comprised of three recently identified proteins: mitochondrial
RNase P protein 1 (MRPP1), MRPP2, and MRPP3 (Holzmann
et al., 2008). An alternative RNase P containing an imported
catalytic RNA has also been described (Puranam and Attardi,
2001). Cleavage at the 30 end of tRNAs is catalyzed by the
nuclease ELAC2 (Brzezniak et al., 2011; Sanchez et al., 2011).
After cleavage, the mtRNA poly-A polymerase (MTPAP) polya-
denylates the mt-mRNAs (Nagao et al., 2008; Piechota et al.,
2006). mt-mRNA abundance is regulated by the SLIRP- LRPPRC
complex, although the exact mechanism is debated. LRPPRC
has been implicated in mt-mRNA transcription, polyadenylation,
translation, and degradation suppression (Baughman et al.,
2009; Chujo et al., 2012; Gohil et al., 2010; Liu et al., 2011;
Ruzzenente et al., 2012; Sasarman et al., 2010).
Despite the concurrent transcription of heavy-strand genes,
their cognate mt-mRNAs reach distinct steady-state levels.
These ten transcripts have distinct half-lives that fall into two
categories: short-lived and long-lived. The complex I transcripts
ND1–ND3 and ND5, and the complex III transcript CYTB
are short-lived (t1/2 = 68–94 min), whereas the complex IV
transcripts cytochrome c oxidase 1 (COX1), COX2, and COX3;
complex V bicistronic transcript ATP6/8; and complex I bicis-
tronic transcript ND4/4L are long-lived (t1/2 = 138–231 min)
(Nagao et al., 2008). These differential mt-mRNA stabilities are
consistent with early observations (Gelfand and Attardi, 1981)
and recent RNA-sequencing analysis (Mercer et al., 2011),
but remain unexplained by transcript length, polyadenylation,
known degradation pathways, or characterized stability factors.
Although the purpose of these differential half-lives is unex-
plored, we note that concentrations of OXPHOS protein
complexes (reviewed by Lenaz and Genova, 2010) tend to
correlate with reported mt-mRNA half-lives (Nagao et al.,
2008). Complex I is the least abundant complex and contains
Figure 1. MitoString Screen for Regulators of mtRNA Processing
(A) Schematic depicting mtDNA transcription (in two continuous units, the heavy and light strands) followed by cleavage into individual mRNAs, tRNAs, and
rRNAs. Pink and turquoise lines represent MitoString probes targeting mRNAs and junctions, respectively.
(B) Location of MitoString probes on the mtDNA heavy and light strands. rRNAs and mRNAs encoded by the mtDNA are labeled in white text. tRNAs are
demarcated by their one-letter symbols. The locations of mRNA, junction, and noncoding probes are denoted in pink, turquoise, and gray, respectively.
Rectangles indicate probes targeting the heavy strand, and triangles indicate probes targeting the light strand.
(C) Comparison of the effects of shLRPPRC and shSLIRP onMitoString probes, shown as log2(fold-change) with respect to shGFP. Probe colors and shapes are
depicted as in (B).
(D) Overview of the MitoString screening approach. Candidates for lentiviral knockdown were selected by identifying MitoCarta proteins containing RNA-binding
domains. Candidate genes were knocked down in WI-38 fibroblasts and the mtRNA levels were assessed 6 days later by the MitoString probes described in (B).
See also Figure S1.subunits encoded by the short-lived mt-mRNAs. Thus, differ-
ences in mt-mRNA abundance may help establish OXPHOS
protein stoichiometry.
Because all mt-mRNA transcripts but one originate from a
single heavy-strand promoter, the observed steady-state levels
are expected to be highly dependent on transcript degradation
rates (Chujo et al., 2012). The helicase SUPV3L1, in complex
with polynucleotide phosphorylase (PNPT1), has been impli-
cated in the degradation of light-strand transcripts, and a
dominant-negative form of either gene stabilizes light-strand
noncoding transcripts and some short-lived heavy-strand
mt-mRNAs (Borowski et al., 2013; Szczesny et al., 2010). How-
ever, both RNAi and dominant-negative experiments targeting
SUPV3L1 or PNPT1 actually decreased the levels of the long-
lived mt-mRNA COX1, indicating that additional degradation or
feedback mechanisms may exist.
Our goal was to systematically identify mitochondrial proteins
that contribute to mtRNA processing. We began with a scalable,
accurate method to measure multiple mtRNAs throughout
the processing stages. Previous approaches for measuringmtRNA levels, such as northern blotting, quantitative PCR
(qPCR), and gene expression-based high-throughput screening
(GE-HTS; Wagner et al., 2008), have been valuable, but are
limited by scalability, strand specificity, or dynamic range,
respectively. Here, we report simultaneous, strand-specific
measurement of multiple precursor and mature mtDNA-en-
coded RNAs following stable genetic silencing of nuclear factors
predicted to play a role in mtRNA biology. We produced a
focused compendium of mtRNA expression across a set of
targeted genetic perturbations, which we mined to probe the
identity and role of nuclear-encoded factors in mtRNA process-
ing. In the process, we identified FASTKD4, a factor that regu-
lates the stability of a subset of mt-mRNAs.
RESULTS
MitoString: A Multiplexed Assay for Precursor
and Mature mtRNAs
We developed MitoString assay for interrogating four types of
transcripts using the nCounter Analysis System (Geiss et al.,Cell Reports 7, 918–931, May 8, 2014 ª2014 The Authors 919
(legend on next page)
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2008), in which fluorescent RNA probes quantitate unamplified
RNA within a crude cell lysate sample. First, we designed a
probe that targets each of the highly abundant mt-mRNA tran-
scripts (Figure 1B), and achieved a coefficient of variation (CV)
of 7%–14% for all but one probe across ten independent
infections of the control hairpin shGFP (Figures S1A and S1B).
Second, we designed probes to two regions of the light-strand
precursor that are transcribed but are not believed to encode a
functional protein. Third, we designed probes that overlap the
junctions of two adjacent genes. These junction probes only
produce signal when bound to the unprocessed precursor
transcript. Probes that assess the precursor strands have lower
signal at baseline and thus are noisier (Figure S1C), but their
levels can be reproducibly induced in response to perturbation.
In addition, we designed probes to detect nuclear-encoded
genes that are important for mitochondrial function, as well as
nuclear-encoded candidate genes, with the vast majority having
a CV of <20% (Figure S1D).
To verify that mtRNA perturbations were measured reliably,
we profiled cells following transduction with PGC-1a, which
induces mitochondrial biogenesis, and shLRPPRC, which
depletes mtRNAs. PGC-1a overexpression increased mature
and immature transcripts (Figures S2A and S2B), as well as nu-
clear-encoded, mitochondrial-localized transcripts (Figure S2C),
as expected. LRPPRC silencing depleted heavy-strand mt-
mRNAs, as found previously (Figure 1C). We further note that
knockdowns of the individual components of the LRPPRC-
SLIRP complex had well-correlated effects on all transcripts
measured byMitoString (Figure 1C), suggesting that hierarchical
clustering of MitoString profiles may be valuable for predicting
gene function.
Prioritizing Candidate mtRNA-Binding Proteins
for Knockdown
With a facile assay for quantifying immature and mature mito-
chondrial transcripts in hand, we proceeded to select genes
that might be involved in mtRNA processing for RNAi-based
silencing. We focused on members of MitoCarta, a high-confi-
dence collection of mitochondrial-localized proteins (Pagliarini
et al., 2008), and prioritized proteins with known or predicted
RNA-binding domains based on Pfam, Gene Ontology (GO)
annotation, or manual curation (Figure 1D; Finn et al., 2008).
We excluded components of the mitochondrial ribosome and
prioritized a total of 107 candidates.
For each of these genes, we selected the three most effective
lentiviral short hairpin RNAs (shRNAs) available from the RNAi
Consortium (Table S1; Experimental Procedures). We screened
WI-38 fetal lung fibroblasts, which are untransformed and
viable after 6 days of strong LRPPRC knockdown. Cells were
infected with hairpins in duplicate and lysed for MitoString
analysis after 6 days of antibiotic selection. Using our nuclearFigure 2. MitoString Profiles for 107 Gene Knockdowns
Heatmap depicts the log2(fold-change) expression level of each of 27 mtDNA p
and ordered by hierarchical clustering (Euclidean distance). Each gene was targe
all hairpins for a given gene is displayed and the genes are hierarchically clu
represents decreased expression with respect to shGFP. Identifiers starting with
See also Figure S2 and Tables S1, S2, S3, S4, and S5.NanoString probes, we were able to measure knockdown
efficiency for most hairpins within the same assay (Table S2).
On each 96-well screening plate, we included five hairpins
targeting nonhuman sequences as RNAi controls, a hairpin
targeting LRPPRC (which is known to deplete mt-mRNAs;
Figure 1C), and a PGC-1a overexpression construct to stimulate
mitochondrial biogenesis (Figures S2A–S2C).
A Compendium of Perturbational Profiles for mtRNA
MitoString quantitation of knockdown perturbations provides a
valuable compendium for gene function prediction and mtDNA
transcript characterization. Each expression value is normal-
ized to a set of endogenous controls and calculated as a fold
change compared with shGFP, one of our controls targeting
nonhuman sequences. Since PGC-1a induction and LRPPRC
knockdown produce the expected mt-mRNA perturbations
(Figures 1C and S2A–S2C), we have confidence that our data
set can identify novel regulators. By hierarchically clustering
the average perturbational profile across hairpins for each of
107 gene knockdowns along each dimension, we can identify
genes and mitochondrial transcripts that may have similar func-
tions (Figure 2; Tables S3 and S4). Unsupervised hierarchical
clustering automatically groups LRPPRC and SLIRP together
with POLRMT, which encodes the RNA polymerase respon-
sible for mtDNA transcription, and SSBP1, which encodes a
protein required for mtDNA replication (Figure 2, cluster C1).
Separately, genes with roles in mtRNA precursor cleavage,
including ELAC2 and MRPP1, also form a strong group based
on the signature of junction probe enrichment (Figure 2, cluster
C3). Unsupervised hierarchical clustering of the MitoString
probes results in automated segregation of light-strand probes,
heavy-strand mRNAs, and heavy-strand junctions (Figure 2).
Principal component analysis further demonstrates the power
of our data set to differentiate these distinct transcript types
(Figure S1F). In particular, the heavy-strand junction and
mRNA probes are separated by principal component 2, which
explains 19% of the variance. The lone mRNA-mRNA junction,
ATP6/8_COX3, is the sole outlier junction, as it behaves like its
mature products, ATP6/8 and COX3. These unsupervised ana-
lyses indicate that many genes targeted for RNAi are grouped
by function and that mtDNA transcripts respond to perturba-
tions in modules.
Knockdown of LRPPRC or SLIRP Depletes All
Heavy-Strand mtRNAs
By mining the compendium, we gain insight into the action of
LRPPRC and SLIRP, which are the strongest regulators tested.
Knockdown of LRPPRC or SLIRP results in depletion of the
heavy-strand precursor and all its resulting mt-mRNAs (Figure 2,
cluster C1). In addition to LRPPRC and SLIRP, POLRMT and
SSBP1 also universally deplete heavy-strand mtRNAs whenrobes across 107 gene knockdowns. mtDNA probes are noted along the top
ted by three distinct lentiviral hairpins and measured in duplicate. The mean of
stered (Euclidean distance). Red represents increased expression and blue
‘‘TRN’’ denote tRNAs. Probe colors are as described in Figure 1B.
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Figure 3. Discordant Expression of Junction and Noncoding Probes Highlights Genes Required for Processing and Degradation
(A) Expression of theCOX1 probe as a log2(expression/shGFP expression) value is plotted for each control (green) and knockdown hairpin (blue denotes nominal
p value < 0.01 byMann-Whitney rank-sum test when comparing six gene-targeted hairpinswith the control hairpins shown; gray denotes p > 0.01). Knockdown of
LRPPRC, SLIRP, and FASTKD4 caused the strongest depletion of COX1.
(B) Expression of the rc_COX1 probe, which targets a noncoding region on the light strand, is plotted as in (A).
(C) The probe count for each knockdown hairpin is plotted for theND4mRNA and ND4_TRNH junction probes. Genes that disproportionally affect one probe are
found offset from the diagonal and labeled (Supplemental Experimental Procedures). Hairpins are colored based on knockdown strength (light blue for worst
hairpin, blue for middle hairpin, dark blue for best hairpin, gray for no knockdown information, and green for control).
(D) The probe count for each knockdown shRNA hairpin is plotted for the ND2 mRNA and TRNM_ND2 junction probe as in (C).
See also Figure S3.knocked down (Figure 2, C1), consistent with our expectation
that depletion of both precursor and mature transcripts should
reflect reduced transcription or mtDNA content. SLIRP and
LRPPRC form a complex that is known to bindmtRNA and affect
mt-mRNA levels (Mili and Pin˜ol-Roma, 2003; Sasarman et al.,
2010), but previous studies have both supported and contested
a role for LRPPRC in transcription (Harmel et al., 2013; Sond-
heimer et al., 2010). Although all heavy-strand probes are
impacted by shLRPPRC and shSLIRP, some junction probes
are less strongly affected than the mRNA probes, suggesting
a dual role for these regulatory proteins in posttranscriptional
stabilization and transcription (Figure 1C). One theory consistent
with our results is that the complex stabilizes the nascent tran-
script, as suggested elsewhere (Harmel et al., 2013). Because
we could quantitate junction probes strand specifically, we922 Cell Reports 7, 918–931, May 8, 2014 ª2014 The Authorswere able to observe that ND6 and most light-strand transcripts
were unaffected by LRPPRC or SLIRP knockdown.
MitoString Highlights Distinct Regulatory Mechanisms
for Coding and Noncoding Antisense Transcripts
Querying the MitoString compendium for specific transcripts,
such as the heavy-strand mRNA COX1, uncovers distinct
regulation for heavy-strand coding and light-strand noncoding
RNAs. We identify nuclear genes whose knockdown alters
COX1 expression relative to the control hairpins, using a rank-
sum statistic at a nominal p value < 0.01 (Figure 3A). On the
left tail of the distribution, we recover the aforementioned
LRPPRC and SLIRP. COX1 is also depleted by knockdown of
FASTKD4 (also known as TBRG4), an uncharacterized protein
that contains a RAP domain with predicted RNA-binding abilities
(Lee and Hong, 2004). Hairpins targeting the uncharacterized
nucleoid component DHX30 also deplete COX1. Interestingly,
depletion of SUPV3L1, which is implicated in mtRNA degrada-
tion, also decreases COX1 levels, possibly due to decreased
mtDNA copy number, as described previously (Khidr et al.,
2008). Silencing of MTPAP also diminishes COX1 levels
markedly, with the exception of one hairpin (Figure 3A). No
knockdowns significantly increased COX1 expression, perhaps
due to its extremely high baseline abundance.
A similar analysis, focusing on the light-strand probe rc_COX1,
reveals that the majority of significant knockdowns increase
rc_COX1 expression (Figure 3B). Since the noncoding portion
of the light strand exists transiently, measuring these regions
can identify degradation machinery. For the rc_COX1 probe,
knockdown of SUPV3L1 induces a strong increase in transcript
levels, confirming the role ofSUPV3L1 in this process (Figure 3B).
However, SUPV3L1 silencing actually decreases the level of
some mt-mRNA transcripts, most notably COX1, COX3, and
ND4 (Figure 2, cluster C3), suggesting that its role in degradation
may be selective. The response of COX1 and rc_COX1 tran-
scripts to systematic RNAi perturbation highlights the distinct
regulation of heavy-strand and light-strand transcripts shown in
Figure 2.
IdentifyingNegative Regulators ofmt-mRNAAbundance
We next sought to identify factors that function to repress the
abundance of mt-mRNAs at steady state, in contrast to LRPPRC
and SLIRP, which stabilize transcripts, by further mining our
compendium. Loss of Mitochondrial GTPase 1 (MTG1) expres-
sion results in an increase of all mt-mRNAs except ND5 (Fig-
ure S2D), and it is the second strongest-scoring gene on the
right tail of the COX1 distribution (Figure 3A). Although it is not
significant when summarized by three hairpins for COX1 indi-
vidually (Figure 3A), measuring multiple genes results in an
intriguing phenotype (Figure S2D). MTG1 has been linked to
respiration and translation in human cell lines, but up to now,
the effect of MTG1 knockdown on mt-mRNA levels had not
been measured (Barrientos et al., 2003; Kotani et al., 2013).
Knockdown of the uncharacterized gene C21orf33 increases
the mt-mRNAs ND1-3, with excellent knockdown-phenotype
correlation, but has a minimal effect on the other transcripts
(Figure S2E). In a complementary analysis using the GNF
Mouse GeneAtlas (Lattin et al., 2008), we found that mRNA
expression of the C21orf33 mouse homolog is well correlated
with nuclear-encoded OXPHOS gene expression (Figure S2F).
Our data offer tantalizing clues, but more research is required
to elucidate the exact roles of these genes.
Identifying Factors that Cleave Precursor Transcripts
A key advantage of the MitoString approach is that it simulta-
neously monitors both precursor and mature transcripts across
a battery of perturbations, allowing identification of specific
cleavage and processing factors. Within our data set, known
cleavage factors form a distinct cluster marked by increased
junction expression concomitant with stable mt-mRNA expres-
sion (Figure 2, cluster C3). These recently discovered factors
include MRPP1 and MRPP2, which encode subunits of the
tRNA 50 end cleavage machinery, and ELAC2, which cleavesthe tRNA 30 end (Brzezniak et al., 2011; Holzmann et al., 2008;
Sanchez et al., 2011).
By comparing the abundance of specific mt-mRNAs with
that of their unprocessed precursor, over all perturbations, we
observe a background distribution from which outliers represent
candidate cleavage factors (Figures 3C and 3D). The activity
of mitochondrial RNase P is estimated by comparing the ND4
transcript with its neighboring ND4_TRNH transcript (Figure 3C).
If the junction is less efficiently cleaved, due to gene silencing,
more unprocessed RNA will remain (Figure 3C). Hairpins target-
ing MRPP1 and MRPP2 have this effect and are consistently
distinct from the background distribution in this case and
in others tested (Figures 3C and S3A–S3C). We similarly
investigate the 30 cleavage site by comparing ND2 counts with
TRNM_ND2 counts (Figure 3D). In this case, we identify ELAC2,
MRPP1, and MRPP2, suggesting that knockdown of RNase P
components can disrupt 30 cleavage, as found previously for
some junctions (Brzezniak et al., 2011; Sanchez et al., 2011).
We also interrogate junctions cleaved by noncanonical mech-
anisms. We find that silencing MRPP1–MRPP3 or ELAC2 does
not influence the ATP6/8_COX3 junction cleavage (Figures 2,
cluster C3, and S3D–S3F). Further, outlier hairpins for this
distribution are driven by mt-mRNA depletion, and not by
ATP6/8_COX3 transcript accumulation, leaving the cleavage
factor for this junction unidentified (Figures S3D–S3F). The 50
junction of TRNQ on the light strand abuts noncoding DNA
and, unexpectedly, is more strongly affected by knockdown of
ELAC2 than by knockdown of MRPP1/2 (Figure 2, cluster C3).
Conversely, TRNF_RNR1 is more strongly regulated by silencing
ofMRPP1/2 and SUPV3L1 than by silencing of ELAC2, although
one ELAC2 hairpin still has a strong effect (Figure 2, cluster C3).
Both cases suggest noncanonical processing.
Impact of Known Disease Genes on mt-mRNA Levels
Our knockdown inventory includes 12 genes that have been
implicated in Mendelian mitochondrial disease (Table S5). The
disease genes MTO1, PUS1, and TRMU encode enzymes with
well-established roles in tRNA modification and efficient trans-
lation, but to our knowledge, their role in regulating human mt-
mRNA abundance has never been tested (Patton et al., 2005;
Wang et al., 2010b; Yan and Guan, 2004; Zeharia et al., 2009).
For the strongest MTO1 knockdown hairpin (13% remaining),
our compendium shows depletion of multiple mt-mRNAs (Fig-
ure 2), confirming similar findings in yeast (Wang et al., 2010b).
Similarly, strong PUS1 knockdown decreases ATP6, COX3,
and CYTB mt-mRNA abundance (Figure 2). On the other hand,
silencing of TRMU has a negligible effect on mt-mRNAs (Fig-
ure 2). In combination, these data suggest that some tRNA
modifications may be necessary for proper mt-mRNA stability.
The disease mechanisms may include both improper tRNA
modification and mt-mRNA depletion.
Our compendium also expands our understanding of a num-
ber of other disease genes (Table S5). A mutation in FASTKD2
has been implicated in COX deficiency (Ghezzi et al., 2008),
and we now find a 2-fold decrease of COX2/3, CYTB, ATP6/8,
and ND3-4/4L-5 mt-mRNA expression under FASTKD2 silenc-
ing by at least one hairpin (Figure 2). PNPT1, which has been
implicated in both RNA degradation (Borowski et al., 2013) andCell Reports 7, 918–931, May 8, 2014 ª2014 The Authors 923
5S rRNA, RNase P RNA, and MRP RNA import (Wang et al.,
2010a), was also recently associated with hearing loss and res-
piratory chain deficiency (Vedrenne et al., 2012; von Ameln et al.,
2012). Our data reveal moderate increases in the short-lived
transcripts CYTB and ND2, and moderate decreases in the
long-lived transcripts COX1–COX3 (Figure 2) in PNPT1-silenced
cells, consistent with previous reports and highlighting the
complexity of this protein’s role in the cell (Borowski et al.,
2013). Knockdown of TIMM8A, a known inner-mitochondrial-
membrane translocase component that was targeted in the
current study because it contains a zinc-finger-like motif, is
correlated with moderately decreased mt-mRNA levels for
almost all transcripts (Figure 2), and has been implicated in
deafness-dystonia syndrome (Aguirre et al., 2006; Swerdlow
et al., 2004).
Identifying Genes that Influence Mature mt-mRNA
Abundance
To identify genes that specifically stabilize mature heavy-strand
mt-mRNAs, we developed an ordered list that incorporates all
of our heavy-strand probe data. We examined the ratio of the
average heavy-strand mature mt-mRNA probes to the average
heavy-strand precursor probes for each knockdown gene (Fig-
ure 4A). Using this measurement, we ordered each gene based
on the rank sum of all hairpins targeting that gene (Figure 4A).
This procedure is complementary to Figures 3C and 3D, which
focus on two individual junctions. Proteins identified through
this method might play a role in posttranscriptional processing,
stability, and degradation.
POLRMT, which encodes the mtRNA polymerase, is among
the highest-scoring hits, causing the ratio of mature mt-mRNA
to precursor RNA to increase when silenced (Figure 4A).
POLRMT has been well studied in vitro, but our study now
perturbs it in vivo. This result suggests that when mtDNA tran-
scription is reduced, the cell’s response is to stabilize mature
mt-mRNAs via an as yet uncharacterized regulatory mechanism.
A number of genes, when silenced, decrease the ratio of
mt-mRNAs to precursor transcripts, suggesting that either the
nascent strand is stabilized and/or the mt-mRNAs are destabi-
lized. As expected, RNase P- and RNase Z-encoding genes
(MRPP1, MRPP2, and ELAC2) are represented here because
they stabilize nascent transcripts. Knockdown of an uncharac-
terized gene, FASTKD4, destabilizes mature transcripts and
has an effect size similar to that produced by knockdown of
known regulators (Figure 4A). FASTKD4 clusters in our study
with MTPAP and the ribosomal protein-encoding MRPS17
(Figure 2, cluster C2). In general, silencing of genes in this cluster
affects the mt-mRNA probes more strongly than the junction
probes and does not affect all mt-mRNAs uniformly. Since
FASTKD4 has not been previously linked to mt-mRNA expres-
sion, we pursued its function in more depth.
Silencing of FASTKD4 Depletes Some, but Not All,
mt-mRNAs
FASTKD4 belongs to a metazoan-specific cohort of proteins
defined by the presence of FAST (Fas-activated serine/threonine
kinase-like) and RAP (RNA-binding domain abundant in Apicom-
plexans) domains. The human genome encodes six of these924 Cell Reports 7, 918–931, May 8, 2014 ª2014 The Authorsproteins (FASTK and FASTKD1–FASTKD5), all of which localize
to the mitochondrion (Simarro et al., 2010), although not all
were identified in the initial MitoCarta compendium (Pagliarini
et al., 2008). Mutations in FASTKD2 are associated with COX
deficiency (Ghezzi et al., 2008), and FASTKD3 knockdown in-
hibits respiration in cultured cells (Simarro et al., 2010). FASTK
encodes a kinase whose mitochondrial localization is disrupted
during UV- or anti-Fas antibody-induced apoptosis (Li et al.,
2004). FASTK also plays a role in alternative splicing in the nu-
cleus, which requires the RAP domain (Izquierdo and Valca´rcel,
2007; Simarro et al., 2007). Unlike FASTK, FASTKD4 does not
have an identifiable kinase active site.
To confirm our screening result that shFASTKD4 depletes a
subset of mt-mRNAs, we began by validating the FASTKD4
knockdown phenotype in an independent cell line (HEK293T).
We used five distinct hairpins against FASTKD4 and used Mito-
String to measure expression of the mitochondrial transcripts
after 8 days of stable knockdown (Figure 4B). In agreement
with our initial screen, only a subset of the mt-mRNA transcripts
were affected (COX1–COX3, ATP6/8, CYTB, and ND3), and we
found that mtDNA was actually increased, ruling out mtDNA
depletion as a mechanism (Figure 4C). ND1 was also consis-
tently upregulated in both cases, whereas ND2, ND4/4L,
and ND5 remained unchanged. Thus, the impact of FASTKD4
silencing on mt-mRNA abundance is robust across five distinct
hairpin sequences and two cell lines. To confirm that this is an
on-target effect of FASTKD4 knockdown, we overexpressed a
FLAG-tagged RNAi-resistant FASTKD4 (FASTKD4-FLAG), as
well as FASTKD4 with four characteristic RAP domain residues
mutated to alanines (FASTKD4mut-FLAG) (Figures 4D and 4E).
FASTKD4-FLAG expression, but not FASTKD4mut-FLAG ex-
pression, is accompanied by recovery in RNA levels for affected
transcripts (Figure 4E), proving that the FASTKD4 knockdown
is responsible for the observed phenotype.
We next used a complementary gene knockout strategy to
perturb FASTKD4 and interrogate its impact on OXPHOS protein
production. Although the knockdown produced a reliable RNA
phenotype, residual FASTKD4 RNA was translated. We gener-
ated a FASTKD4 knockout (FASTKD4ko) in HEK293T cells using
the CRISPR/Cas9 system (Hsu et al., 2013), which enabled as-
says in the complete absence of FASTKD4. In our FASTKD4ko
cell line, we identified three indels at the FASTKD4 locus
that generated protein-terminating frameshifts, resulting in the
absence of full-length protein (Figure 4F). In FASTKD4ko, we
observed a reduced abundance of complex IV subunit COX2
protein that was rescued by FASTKD4-FLAG overexpression
(Figures 4G and 4H). Complex I, II, III, and V nuclear subunits
were unaffected, consistent with our screening results and the
dependence of these complexes on mtDNA-encoded subunits
(Figure 4H). Thus, two independent genetic strategies indicate
that FASTKD4 is required for the proper expression of a specific
subset of mtRNAs and, in the case of COX2, the protein product.
The Stability of a Subset of mtRNA Transcripts Requires
FASTKD4
Assuming that all heavy-strand transcripts are transcribed
concurrently, we hypothesized that the differential abundance
of mt-mRNAs following silencing of FASTKD4 is due to
Figure 4. Loss of FASTKD4 Leads to Loss of a Subset of Steady-State mtDNA Gene Products
(A) The geometric mean of heavy-strand mRNA probe counts divided by the geometric mean of heavy-strand junction probe counts is plotted for each hairpin.
Control hairpins are in green and knockdown hairpins are in blue or gray (blue represents nominal p value < 0.01 by Mann-Whitney rank-sum test).
(B) MitoString results normalized to shLacZ for five distinct shFASTKD4 hairpins in HEK293T cells. Control hairpin is shown in black, FASTKD4 hairpins are
shown in red.
(C) Relative mtDNA content in shLACZ knockdown cells compared with shFASTKD4 knockdown cells as measured by qPCR; *p < 0.05 (two-tailed unpaired
t test).
(D) Western blot showing expression of FASTKD4-FLAG and FASTKD4 (detected by FASTKD4 antibody, top), tubulin (loading control, middle), and GFP-FLAG
(overexpression control, bottom) in stable HEK293T cell lines. Cells are overexpressing RNAi-resistant FASTKD4-FLAG and FASTKD4mut-FLAG (with RAP
domain point mutations) or mitoGFP-FLAG in the presence of shLACZ (control) or shFASTKD4 knockdown, as indicated.
(E) Relative expression of each mt-mRNA probe quantified by MitoString, shown for the four cell lines depicted in (D).
(F) Western blot showing expression of FASTKD4 and tubulin in the FASTKD4ko CRISPR/Cas9 cell line.
(G) Western blot showing expression of FASTKD4-FLAG and FASTKD4 (detected by FASTKD4 antibody, top), tubulin (loading control, middle), and GFP-FLAG
(overexpression control, bottom) in control and FASTKD4ko cell lines with overexpression of FASTKD4-FLAG, FASTKD4mut-FLAG, and mtGFP-FLAG as
indicated (samples run on same gel with irrelevant lane removed).
(H) Western blot showing respiratory complex protein expression in control and FASTKD4ko cell lines, withmtGFP-FLAG or FASTKD4-FLAG overexpression as
indicated. Three concentrations of each cell lysate were loaded as indicated. In all panels, error bars represent SEM, n = 3.differential degradation rates. To measure RNA stability within
themitochondrion, we blocked POLRMT-mediated transcription
with media containing a high concentration of ethidium bromide
(ETBR) (Nagao et al., 2008). We quantitated the mt-mRNAs
using qPCR following 6 hr of ETBR treatment, during whichtime period mitochondrial transcription was suspended. We
determined the remaining fraction of RNA by comparing the
ETBR-treated RNAwith the untreated RNA. Of the six transcripts
that were downregulated at steady state in FASTKD4 knock-
down cells (Figure 4B), COX2, ND3, and COX1 also showed aCell Reports 7, 918–931, May 8, 2014 ª2014 The Authors 925
Figure 5. FASTKD4 Is Required for Stability of a Subset of mt-
mRNAs
(A) The fraction of RNA that remained after ETBR transcription inhibition for
6 hr is plotted for each mt-mRNA as measured by qPCR in shLACZ and
shFASTKD4 cell lines.
(B andC) The fraction of remaining RNA is also plotted specifically for (B)COX1
and (C) ND1 in control or knockout cell lines expressing FLAG-taggedmtGFP,
FASTKD4, and FASTKD4mut. Error bars represent SEM, n = 3. *p % 0.05
(two-tailed unpaired t test).strong decrease in the remaining fraction of RNA under ETBR
treatment (Figure 5A), suggesting an increased degradation
rate. CYTB also trended downward, but not significantly. The
only transcripts that were depleted (Figure 4B) but not destabi-
lized in our assay wereCOX3 and ATP6/8 (Figure 5A). Regulation
of these two transcripts, which are part of the stable ATP6/
8_COX3 precursor, appears to be more complicated. By per-
forming the same assay in our FASTKD4ko, we observed
destabilized COX1 and unchanged ND1, consistent with
shFASTKD4 (Figures 5B and 5C). Further, to rule out off-
target RNAi effects, we rescued the COX1 destabilization with
FASTKD4-FLAG overexpression, but not with overexpression
of FASTKD4mut-FLAG (Figure 5B).
FASTKD4 Associates with mtRNAs in the Matrix
We sought to define the suborganellar localization of FASTKD4
relative to the mt-mRNAs. FASTKD4, alongside soluble protein
Cyclophilin D, was extractable with alkaline carbonate treatment
of isolated mitochondria (Figure 6A). Additionally, FASTKD4 in
mitoplasts was resistant to proteinase K treatment, alongside
matrix protein Cyclophilin D (Figure 6A). All measured proteins
were substrates for Proteinase K. Collectively, these studies
indicate that FASTKD4 is a soluble protein that resides within
the mitochondrial matrix.
Because FASTKD4 appears to stabilize mt-mRNAs, we inves-
tigated its binding to mtRNA by immunoprecipitating endoge-
nous FASTKD4 from mitochondrial lysates and testing for
mtRNA enrichment using qPCR. As controls, we immunoprecip-
itated TFAM, a known DNA-binding protein that is not expected
to bind RNA, and LRPPRC, a knownRNA-binding protein, along-
side FASTKD4 in both wild-type and FASTKD4ko HEK293T cells
(Figure 6B). In agreement with published results (Chujo et al.,
2012; Sasarman et al., 2010), LRPPRC is associated with926 Cell Reports 7, 918–931, May 8, 2014 ª2014 The AuthorsCOX1 mRNA (Figure 6C). In addition, LRPPRC associates with
12S rRNA, but not nuclear 18S rRNA (Figures 6D and 6E). In
comparison, TFAM is not appreciably enriched for either RNA
(Figures 6C and 6D). Similar to what is observed for LRPPRC,
FASTKD4 immunoprecipitation enriches both COX1 mRNA
and 12S rRNA, as compared with TFAM immunoprecipitation,
in wild-type cells, but does not enrich nuclear 18S rRNA (Figures
6C–6E). Intriguingly, FASTKD4 seems to bind 12S almost as
strongly as LRPPRC, but is a weaker binder of COX1. In
FASTKD4ko cells, RNA enriched from FASTKD4 immunoprecip-
itation is indistinguishable from that enriched from TFAM and
immunoglobulin G (IgG) immunoprecipitation. This proves that
the RNA enrichment of COX1 and 12S rRNA is specifically due
to FASTKD4 immunoprecipitation and is not an antibody artifact
(Figures 6F–6H).
In addition to qPCR, we assessed our TFAM, FASTKD4, and
LRPPRC immunoprecipitations with MitoString (Figures 6I and
6J). MitoString is valuable in this context because it allows
strand-specific multiplexed measurement with a minimal sam-
ple. We found that the majority of heavy-strand abundant
transcripts were enriched in both LRPPRC and FASTKD4 immu-
noprecipitations in comparison with TFAM immunoprecipitation
(Figures 6I and 6J). In contrast, light-strand probes targeting
ND6 and light-strand intergenic space (rc_ND5, rc_ND5_ND6,
and rc_TRNQ_TRNM) had less specific enrichment (Figure 6I).
The heavy-strand junction probes spanning the RNR2_TRNL1
junction and the ATP6/8_COX3 junction were enriched in both
FASTKD4 and LRPPRC immunoprecipitations. These results
for LRPPRC are well correlated with previous findings obtained
by qPCR (Chujo et al., 2012). In addition, our approach interro-
gates junction transcripts, especially on the light strand, that
do not appear enriched relative to TFAM immunoprecipitation.
RNR2_TRNL1 is enriched in both LRPPRC and FASTKD4 immu-
noprecipitations at the same level as many of the mRNA genes.
Our distinct approach and the inclusion of TFAM as a negative
control demonstrate that FASTKD4 associates with mtRNAs,
and further validate LRPPRC as an mtRNA-binding protein.
DISCUSSION
The expression of mtDNA requires nuclear-encoded proteins,
yet at present we lack a full molecular description of this system.
Previous approaches for measuring mtRNA, including northern
blotting, qPCR, and next-generation sequencing, have been
valuable but are limited by a lack of strand specificity or sample
throughput. In the current study, we establish a facile assay,
called MitoString, to systematically monitor precursor and
mature mtRNA species following silencing of over 100 candidate
nuclear-encoded factors. MitoString enables us to identify and
classify mtRNA regulators based on their roles in transcription,
cleavage, and stability. Through this compendium, we have
expanded our understanding of previously characterizedmtRNA
processing proteins and implicated new players in this pathway,
including the regulator FASTKD4.
Our approach, which measures both mature and precursor
transcripts (Figure 1), implicates the LRPPRC-SLIRP complex
in the production or stability of the heavy-strand precursor.
Previous reports have implicated LRPPRC in promoting
transcription (Liu et al., 2011; Sondheimer et al., 2010) or the sta-
bility of individual mt-mRNAs (Chujo et al., 2012; Ruzzenente
et al., 2012). We find that silencing of SLIRP or LRPPRC primarily
affects the abundance of the heavy-strand precursor, indicating
a role for the complex in either transcription or stabilization of
the precursor (Figure 2). This decrease is accompanied by a
more pronounced downregulation of mature heavy-strand
mt-mRNAs, which may suggest a secondary role in mature
transcript stability. In contrast, Gohil et al. (2010) measured
precursors in LRPPRC-silenced cells by qPCR, which is not
strand specific, and found no change in precursor abundance.
Our method assesses just the heavy strand and reveals a 4-
fold decrease in the same TRNM_ND2 junction upon LRPPRC
silencing (Figure 2). LRPPRC or SLIRP silencing has no effect
on the light-strandmRNAND6 by our assay (Figure 2), consistent
with strand-specific northern blot measurements (Ruzzenente
et al., 2012) and in contrast to strand-insensitive qPCR results
(Gohil et al., 2010). Recently, GRSF1 was implicated as a binder
and regulator of ND6 and its precursor strand, suggesting that a
distinct mechanism operates on the light strand (Antonicka et al.,
2013; Jourdain et al., 2013). Additionally, other investigators
(Chujo et al., 2012) and we have found that LRPPRC binds
heavy-strand transcripts with a higher abundance and specificity
than light-strand transcripts, which is consistent with our steady-
state mtRNA findings.
We confirm the role of proteinaceous RNase P in the cleavage
of tRNA 50 junctions and identify noncanonical cleavage sites.
The MitoString profiles of RNase P subunits MRPP1 and
MRPP2 knockdowns are well correlated, whereas the effect of
MRPP3 is weaker (Figures 2, 3C, and 3D). Our comprehensive
approach builds on earlier findings focused on MRPP1 and a
subset of junctions (Holzmann et al., 2008), as well as work
focused on MRPP1 and MRPP3 (Sanchez et al., 2011). We
also identify a few exceptions to this canonical cleavage pro-
cess. On the light strand, ELAC2 plays a role in the 50 cleavage
of TRNQ, which excises it from surrounding noncoding DNA
(Figure 2, cluster C3). Also, TRNF_RNR1, which we expect to
be regulated by ELAC2, is more strongly regulated by silencing
of MRPP1/2 and SUPV3L1 (Figure 2, cluster C3). Consistent
with this, this same TRNF_RNR1 junction was previously re-
ported to be unaffected by ELAC2 small interfering RNA (siRNA)
knockdown (Brzezniak et al., 2011). In a previous study,
sequencing results suggested that knockdown of ELAC2 and
RNase P components did not affect all tRNA junctions (Sanchez
et al., 2011). However, in all of our tested junctions on the heavy
strand (excepting ATP6/8_COX3), either one or both of these
components were involved (Figure 2). The discrepancy may
stem from the prior study’s exclusion of large precursor frag-
ments due to size selection for tRNA-sized transcripts (Sanchez
et al., 2011). Our assay revealed no obvious candidate for pro-
cessing of the ATP6/8_COX3 junction, as all outlier hairpins
were driven by a decrease in mt-mRNA levels, not an increase
in junction content (Figures S3D–S3F).
Although SUPV3L1 clearly plays a role in the degradation of
light-strand transcripts, we find it has contrasting effects on
different classes of mt-mRNAs (Figure 2). The short-lived ND1
and ND2 transcripts are increased, whereas the long-lived
COX1-3 transcripts are actually decreased, suggesting thatSUPV3L1 may not be responsible for all degradation within
the mitochondria. These contrasting effects were previously
demonstrated (Szczesny et al., 2010), but only for a subset of
mt-mRNAs. Here, we obtained data for all transcripts simulta-
neously. For the TRNF_RNR1 and TRNV_RNR2 junctions, which
we expect to be a readout for transcriptional initiation, hairpins
targeting SUPV3L1 are the second-strongest inducers of
expression (Figure 2, cluster C3). This increased transcription
may pertain only to early-termination transcripts, which end
after the second rRNA, since the RNR2_TRNL1 junction and
other heavy-strand junctions are not increased (Figure 2, cluster
C3). Therefore, SUPV3L1 depletion may increase ribosome
production.
We find that FASTKD4 regulates a specific subset of mt-
mRNAs. In general, FASTKD4 silencing depletes transcripts
that are long-lived while sparing the precursor strand (Figure 4B).
The sole exceptions are ND3, a short-lived depleted transcript,
and ND4/4L, a long-lived unaffected transcript. Most of the
affected mt-mRNAs also have an increased degradation rate in
both FASTKD4 knockdown and knockout cells (Figures 5A and
5B). Thus, we hypothesize that FASTKD4 may serve to shield a
specific set of mt-mRNAs from degradation by SUPV3L1 or an
as yet unidentified degradation machinery. Unexpectedly,
ATP6 and COX3 do not have an increased degradation rate
by our assay (Figure 5A); however, the ATP6/8_COX3 precursor
is the sole mtDNA gene-gene junction and is relatively stable
compared with other precursors, as estimated by probe counts.
The factor responsible for ATP6/8_COX3 cleavage remains
undetermined and we expect that a full understanding of this
mechanism will resolve the discrepancy we observe.
We cement a role for FASTKD4 in mtRNA metabolism based
on the above findings, previous studies, and our immunopre-
cipitation of FASTKD4-associated mtRNA. FASTKD4 contains
a RAP domain in common with experimentally validated RNA-
binding proteins (Lee and Hong, 2004) and is found in a
genome-wide mRNA-binding resource (Castello et al., 2012).
Here, we show that FASTKD4 is localized to the mitochondrial
matrix (Figure 6A) and associates with mtRNAs in a specific
way (Figures 6C–6I). Our immunoprecipitation assay does
not distinguish among the heavy-strand transcripts in terms of
strength of association with FASTKD4, because this protein
associates with all heavy-strand transcripts. However, mtRNA
susceptibility to degradation may be influenced in part by
the activity of another, as yet unidentified protein that requires
FASTKD4 binding.
Why the mitochondrion maintains mt-mRNAs at such dispa-
rate levels is unknown, but we propose that it may provide a
mechanism for ensuring proper OXPHOS complex stoichiom-
etry. Across tissues, the molar ratios of different complexes
are robust, but the mechanism that generates this stability is
unknown (Benard et al., 2006). Complex I is consistently the least
abundant among the OXPHOS complexes (Lenaz and Genova,
2010), andwith theexceptionof thebicistronicND4/4L transcript,
mtDNA-encoded complex I transcripts have half-lives of <90min
(Nagao et al., 2008). In contrast, complexes IV and V are present
at 3–12 times the concentration of complex I, a stoichiometry
that we suggest could be metered in part by higher levels of
complex IV and V component transcripts (COX1-3 and ATP6/8),Cell Reports 7, 918–931, May 8, 2014 ª2014 The Authors 927
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whose half-lives range from 138 to 231 min. Thus, the precise
regulation of mt-mRNA transcript levels by factors such as
FASTKD4 and SUPV3L1 may be important for ensuring proper
OXPHOS complex stoichiometry and function.
We anticipate that in the future, MitoString may prove useful
for interrogating the role of mt-mRNA processing directly in
tissues from patients with mitochondrial disease. Our current
study includes an analysis of 12 previously established disease
genes (Table S5), three of which were previously linked to aber-
rant expression of mt-mRNAs in humans. Our current compen-
dium demonstrates that MTO1, PUS1, and FASTKD2 loss of
function may also cause aberrant expression of mtRNAs.
Our results point to additional modes of pathogenesis that may
be at play in these disorders. As new genetic variants in mtRNA
processing factors are identified in patients, a key challenge will
be to prove their pathogenicity. MitoString is a highly quantitative
and systematic approach for measuring mitochondrial gene
expression that in principle can be easily applied to patient
biopsy specimens. MitoString may therefore be a useful
companion diagnostic for detecting aberrant expression of the
mtDNA genome in human diseases.
EXPERIMENTAL PROCEDURES
Cell Culture
WI-38 fibroblasts and HEK293T cells were cultured in high-glucose Dulbec-
co’s modified Eagle’s medium (DMEM; Cat. No. 11995; Invitrogen) supple-
mentedwith 10% fetal bovine serum (Cat. No. F6178; Sigma) and 13 penicillin,
streptomycin, and glutamine (Cat. No. 10378-016; Invitrogen) at 37C with
5% CO2.
Immunoblotting
Protein was electrophoresed on a 12% Novex Tris-glycine polyacrylamide gel
at constant voltage (125 V). The gel was transferred to a polyvinylidene difluor-
ide membrane (Trans-Blot Turbo Transfer System). Membranes were blocked
for 1 hr at room temperature in Tris-buffered saline with 0.1% Tween-20 and
5% BSA (TBST-BSA). Membranes were incubated with primary antibody in
TBST-BSA overnight at 4C (Table S6). Secondary antibody was used at
1:5,000 for 1 hr at room temperature.Membranes were developed usingWest-
ernLightning Plus-ECL.
Screen
The three best hairpins per gene were selected, and then produced and
arrayed by the RNAi Consortium (TRC) as previously described (Moffat
et al., 2006).
WI-38 cells were seeded, infected after 24 hr, and selected 24 hr later. At
6 days postinfection, the cells were lysed with RLT buffer (Invitrogen) and
b-mercaptoethanol (1:100), and frozen. RLT lysates were processed with a
custom MitoString code set from NanoString Technologies per the manufac-
turer’s instructions (Geiss et al., 2008). Screen details and data processing are
described in Supplemental Experimental Procedures.Figure 6. FASTKD4 Is Localized to the Matrix and Physically Associate
(A) Western blot showing the presence of FASTKD4, OXA1L, COX2, and Cyclop
K digestion of mitoplasts.
(B)Western blot showing the presence of LRPPRC, FASTKD4, and TFAMafter imm
(KO) cells.
(C–E) qPCR was used to measure enrichment of (C) COX1mRNA, (D) 12S rRNA,
IgG from wild-type cells.
(F–H) qPCR-measured enrichment of transcripts measured in (C)–(E) under id
represent SEM, n = 3.
(I) RNA abundance (% input) after FASTKD4 or TFAM immunoprecipitation in wi
(J) RNA abundance (% input) after LRPPRC or TFAM immunoprecipitation in wilProtein Expression
plexFLAG was generated from plex-TRC-983 (TRC) by molecular cloning.
pDONR223-FASTKD4 from a previously described cDNA library (Pagliarini
et al., 2008) was mutagenized via QuikChange mutagenesis (Agilent) using
the primers listed in Table S7. mtGFP was a gift from Y. Sancak. All cDNAs
were cloned into plexFLAG via the Gateway system (Invitrogen).
Lentiviral Production and Infection
For follow-up experiments, shRNA lentiviral vectors (TRC) and FLAG-tagged
expression constructs were used to produce virus and infect HEK293T cells
as previously described (Baughman et al., 2009). For selection, 4 mg/ml
puromycin or 5 mg/ml blasticidin was used.
mtDNA Quantitation
mtDNA quantification was performed as previously described (Baughman
et al., 2009)
Mitochondrial Isolation, Na2CO3 Extraction, and Proteinase K
Protection
HEK293T cells were suspended in isolation buffer (220 mM mannitol, 70 mM
sucrose, 5 mM HEPES, 1 mM EGTA, pH 7.4 + cOmplete, EDTA-free Protease
Inhibitor Cocktail [Roche]) and lysed using a cell disruption vessel (Parr Instru-
ment) pressurized to 800 psi with nitrogen followed by homogenization with
five strokes of a Teflon Potter Elvehjem homogenizer. Crude mitochondria
were isolated by differential centrifugation at 600 g and 8,000 g. Mitoplasts
were created by swelling with H2O on ice and were stabilized in 137 mM
KCl, 2.5 mM MgCl2, 10 mM HEPES pH 7.2; pelleted at 8,000 g; and resus-
pended in isolation buffer. Na2CO3 extraction was performed on crude
mitochondria, and proteinase K protection was performed on mitoplasts as
previously described (Ryan et al., 2001).
Measurement of RNA Half-Lives
HEK293T cell lines were seeded the day before exposure to media with and
without 1 mg/ml ETBR. After 6 hr, the cells were lysed with RLT (QIAGEN) for
RNA extraction.
RNA Isolation and qPCR
RNA was isolated using the RNeasy protocol with DNase I treatment
(QIAGEN). cDNA was transcribed using Superscript III First-Strand Synthesis
Supermix (Invitrogen). qPCR was performed with a 7500-FAST ABI instrument
and 23 Taqman FAST Advanced master-mix (Applied Biosystems) with
mt-mRNA probes as described previously (Gohil et al., 2010).
RNA Immunoprecipitation
Isolated crude mitochondria were lysed in lysis buffer (50 mMHEPES [pH 7.4],
150 mM NaCl, 2 mM EDTA, 1% Triton, RNase Inhibitor). Lysates were treated
with Turbo DNase for 1 hr at 37C. After spinning at 16,000 g for 10 min at 4C,
the supernatant was preclearedwith Protein A agarose beads for 40min at 4C
with rotation. The beads were spun out and the supernatant was incubated
with antibody overnight at 4C with rotation. Fresh Protein A agarose beads
were blocked overnight with 1% BSA, 100 mg/ml heparin, and 100 mg/ml yeast
tRNA in lysis buffer. The next day, the beads were washed three times with
lysis buffer, added to the lysate-antibody mix, and incubated with rotation
for 2 hr at 4C. The bead complex was washed three times with lysis buffers with mtRNAs
hilin D in isolated mitochondria, with carbonate extraction and with proteinase
unoprecipitation of each protein or IgG control in control (WT) and FASTKD4ko
and (E) 18S rRNA with immunoprecipitation of TFAM, FASTKD4, LRPPRC, and
entical immunoprecipitation conditions, but in FASTKD4ko cells. Error bars
ld-type cells as measured by MitoString.
d-type cells. Points represent each duplicate.
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and three times with 500 mM NaCl lysis buffer. RNA samples were eluted with
300 ml 1 M NaHCO3, 1% SDS at room temperature for 15 min. Beads were
spun down and the supernatant was added to 12 ml 5 M NaCl. Then 700 ml
of RLT buffer was added for RNA isolation. Protein samples were boiled in
sample buffer for immunoblotting.
CRISPR Knockout Cell Line Generation
sgRNA and U6 primers (Table S7) were used to amplify the pX064 plasmid
(a gift from F. Zhang) as previously described (Hsu et al., 2013). The PCR
product was cotransfected with the Cas9 plasmid (a gift from F. Zhang) into
HEK293T cells with XTreme Gene transfection reagent per the manufacturer’s
instructions. Cells were single-cell cloned and screened by western blot for
FASTKD4 protein. The identified knockout was verified by PCR followed by
subcloning and Sanger sequencing.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Experiments,
three figures, and seven tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.03.035.
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